TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10511450

Group type: EXPERIMENTAL
Intervention: Verb generation in L1 (Mandarin)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Verb generation in L2 (English)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Comparison of verb generation vs word repetition in L1 and L2
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Within-subject analysis of verb generation minus word repetition
Number of subjects: 7

Group type: COMPARATOR
Intervention: Comparison of differences in frontal peaks
Number of subjects: 7
Study: 7554754

Group type: COMPARATOR
Intervention: No fluid ingestion (trial A)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ingestion of 8% maltodextrin solution (trial B)
Number of subjects: 12
Study: 2111658

Group type: EXPERIMENTAL
Intervention: Amikacin 7.5 mg/kg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Amikacin 15 mg/kg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 6
Study: 6115853

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 976

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 976

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 976
Study: 30887717

Group type: EXPERIMENTAL
Intervention: Ankle block with 8-10 mL of 0.25% bupivacaine before surgery (Group N)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Peri-incisional infiltration with 0.25% bupivacaine preoperatively (Group P)
Number of subjects: 75

Group type: COMPARATOR
Intervention: No regional analgesic pretreatment (Group C)
Number of subjects: 75
Study: 27737326

Group type: COMPARATOR
Intervention: Vitamin D and calcium supplementation, sedentary (CDG, n = 33)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Vitamin D and calcium supplementation with aquatic exercises (DTG, n = 54)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group lacking vitamin D and calcium supplementation, sedentary (CG, n = 17)
Number of subjects: 104
Study: 27686347

Group type: EXPERIMENTAL
Intervention: NAVA
Number of subjects: 128

Group type: COMPARATOR
Intervention: PSV
Number of subjects: 128
Study: 24374798

Group type: EXPERIMENTAL
Intervention: Immediate release tablet (IRT)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Food (fed condition)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Omeprazole co-administration
Number of subjects: 47
Study: 20953877

Group type: EXPERIMENTAL
Intervention: Hemodilution therapy using automated erythrocytapheresis
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no hemodilution therapy)
Number of subjects: 61
Study: 19491388

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (vitamins C and E, beta-carotene, zinc, and selenium) at nutritional doses
Number of subjects: 5220

Group type: COMPARATOR
Intervention: Baseline serum beta-carotene concentrations
Number of subjects: 5220

Group type: COMPARATOR
Intervention: Baseline serum vitamin C concentrations
Number of subjects: 5220

Group type: COMPARATOR
Intervention: Baseline serum zinc concentrations
Number of subjects: 5220
Study: 17083283

Group type: EXPERIMENTAL
Intervention: MTV-style video clips (with jump cuts)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous video clips
Number of subjects: 0
Study: 15016557

Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03%
Number of subjects: 26

Group type: COMPARATOR
Intervention: Travoprost 0.004%
Number of subjects: 26
Study: 11706771

Group type: EXPERIMENTAL
Intervention: Educational program on postoperative pain management
Number of subjects: 787

Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 787
Study: 9022540

Group type: EXPERIMENTAL
Intervention: Exercise (walking for 90 min at 60% of maximal oxygen uptake)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 22
Study: 7954482

Group type: EXPERIMENTAL
Intervention: moclobemide 300 mg daily (increased to 400 mg if necessary)
Number of subjects: 130

Group type: COMPARATOR
Intervention: maprotiline 75 mg daily (increased to 100 mg if necessary)
Number of subjects: 130
Study: 2959439

Group type: EXPERIMENTAL
Intervention: Guar granules (5 g) sprinkled over food for 4 weeks
Number of subjects: 18
Study: 29864548

Group type: EXPERIMENTAL
Intervention: Tobacco and physical activity intervention including motivational counseling, behavior change plan, and nicotine replacement therapy
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Medication adherence and heart-healthy AN diet intervention including motivational counseling, behavior change plan, and medication bag
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Both interventions (Group 1 and Group 2)
Number of subjects: 300
Study: 27410244

Group type: EXPERIMENTAL
Intervention: Verbal cognitive task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visual cognitive task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motor task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no prior task)
Number of subjects: 0
Study: 24240354

Group type: EXPERIMENTAL
Intervention: Polyhexamethylene biguanide‐preserved multipurpose solution
Number of subjects: 218

Group type: COMPARATOR
Intervention: One‐step peroxide disinfection system
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Both lens care groups combined
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: High levels of bacterial bioburden on lid margins
Number of subjects: 218
Study: 22790678

Group type: EXPERIMENTAL
Intervention: 40,000 IU vitamin D(3) per week for 6 months
Number of subjects: 230

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study: 21635279

Group type: EXPERIMENTAL
Intervention: Root surface polishing (test sites)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Root planing (control sites)
Number of subjects: 10
Study: 18573649

Group type: EXPERIMENTAL
Intervention: Current asthma symptoms assessment
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Controller medication usage
Number of subjects: 119
Study: 17044205

Group type: EXPERIMENTAL
Intervention: Intra-observer agreement
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Overall agreement
Number of subjects: 377
Study: 14551773

Group type: EXPERIMENTAL
Intervention: r-HuEPO treatment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 16
Study: 10936477

Group type: EXPERIMENTAL
Intervention: Aspirin alone
Number of subjects: 1073

Group type: EXPERIMENTAL
Intervention: Aspirin combined with low, ineffective doses of warfarin
Number of subjects: 1073

Group type: EXPERIMENTAL
Intervention: High-risk categorization by stratification schemes
Number of subjects: 1073

Group type: EXPERIMENTAL
Intervention: Patients >75 years old classified as high risk
Number of subjects: 1073

Group type: EXPERIMENTAL
Intervention: Patients >75 years old classified as low risk by one scheme
Number of subjects: 1073
Study: 8716524

Group type: EXPERIMENTAL
Intervention: Nasal cannula oxygen delivery
Number of subjects: 11

Group type: COMPARATOR
Intervention: Nasopharyngeal catheter oxygen delivery
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Both methods at 0.5 liters per minute
Number of subjects: 11
Study: 1579136

Group type: EXPERIMENTAL
Intervention: Endoscopic sclerotherapy
Number of subjects: 129

Group type: COMPARATOR
Intervention: Endoscopic ligation
Number of subjects: 129
Study: 3901790

Group type: EXPERIMENTAL
Intervention: DHE/H5,000 (0.5 mg dihydroergotamine plus 5,000 IU heparin)
Number of subjects: 880

Group type: EXPERIMENTAL
Intervention: DHE/H2,500 (0.5 mg dihydroergotamine plus 2,500 IU heparin)
Number of subjects: 880

Group type: EXPERIMENTAL
Intervention: H5,000 (5,000 IU heparin alone)
Number of subjects: 880

Group type: EXPERIMENTAL
Intervention: DHE (0.5 mg dihydroergotamine alone)
Number of subjects: 880

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 880
Study: 31452942

Group type: EXPERIMENTAL
Intervention: Experimental denture adhesive (test adhesive) applied with a precision applicator as continuous strips
Number of subjects: 83

Group type: COMPARATOR
Intervention: Marketed denture adhesive (positive control) applied using a flat ribbon nozzle as dabs
Number of subjects: 83

Group type: COMPARATOR
Intervention: No adhesive
Number of subjects: 83
Study: 29370766

Group type: EXPERIMENTAL
Intervention: Advance Care Planning (ACP) intervention with standardized education programme for nursing home staff, implemented over 4 months.
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Nursing home staff education and communication strategies.
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Facilitators of ACP implementation.
Number of subjects: 765

Group type: EXPERIMENTAL
Intervention: Barriers to ACP implementation.
Number of subjects: 765
Study: 26708093

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) application
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo KT application
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (without KT application)
Number of subjects: 60
Study: 25056233

Group type: EXPERIMENTAL
Intervention: Single-anastomosis gastric bypass (SAGB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Laparoscopic Roux-en-Y gastric bypass (RYGB)
Number of subjects: 0
Study: 22956574

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (non-CKD)
Number of subjects: 0
Study: 19896326

Group type: EXPERIMENTAL
Intervention: THC:CBD extract
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: THC extract
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 17570858

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg per day
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 15185453

Group type: EXPERIMENTAL
Intervention: Phacoemulsification with pars plana infusion (Group B)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard phacoemulsification (Group A)
Number of subjects: 64
Study: 11480539

Group type: EXPERIMENTAL
Intervention: Cisapride (7.5 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 9602871

Group type: EXPERIMENTAL
Intervention: Calcipotriol dilution series (range 0.016-250 micrograms/mL)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Calcipotriol 2 micrograms/mL citrate-buffered isopropanol solution applied under occlusion for 48 h using small Finn Chambers
Number of subjects: 180
Study: 7720502

Group type: EXPERIMENTAL
Intervention: Accelerated Radiotherapy (AR)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Routine Radiotherapy (RR)
Number of subjects: 177
Study: 2810183

Group type: EXPERIMENTAL
Intervention: IV latamoxef disodium
Number of subjects: 229

Group type: COMPARATOR
Intervention: IV combination of cefuroxime and metronidazole
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 229
Study: 1106262

Group type: EXPERIMENTAL
Intervention: Oral hyperimmune milk globulin (specific protein from hyperimmunized cow colostrum)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 31739839

Group type: EXPERIMENTAL
Intervention: Donafenib 200 mg bid
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Donafenib 300 mg bid
Number of subjects: 27
Study: 29339585

Group type: EXPERIMENTAL
Intervention: LigaSure® system
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Harmonic® system
Number of subjects: 20
Study: 25504949

Group type: EXPERIMENTAL
Intervention: Exercise (supervised, individualized treadmill exercise 2-3 times/week for 9-12 weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 14
Study: 23677137

Group type: EXPERIMENTAL
Intervention: iMics1 NY-60 IOL
Number of subjects: 100

Group type: COMPARATOR
Intervention: AcrySof SN60WF IOL
Number of subjects: 100
Study: 22123473

Group type: EXPERIMENTAL
Intervention: 24% sucrose solution
Number of subjects: 47

Group type: COMPARATOR
Intervention: Usual care (comfort measures only)
Number of subjects: 47
Study: 19955882

Group type: EXPERIMENTAL
Intervention: Meditation (2 hours per week for 18 weeks, total of 36 hours)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Control group (no meditation treatment)
Number of subjects: 242
Study: 16881989

Group type: EXPERIMENTAL
Intervention: Doula group
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 600
Study: 15616119

Group type: EXPERIMENTAL
Intervention: Gadobenate dimeglumine (0.1 mmol/kg)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Gadopentetate dimeglumine (0.2 mmol/kg)
Number of subjects: 34
Study: 11915003

Group type: EXPERIMENTAL
Intervention: Mycobacterium avium complex (MAC) prophylaxis
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Nonadherence to both MAC prophylaxis and antiretroviral therapy
Number of subjects: 643
Study: 10091404

Group type: EXPERIMENTAL
Intervention: Gilbert's syndrome (associated with UGT1A (TA)7 variant)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (neonates without Gilbert's syndrome)
Number of subjects: 102
Study: 8527468

Group type: EXPERIMENTAL
Intervention: Schizophrenic patients rated low in affective expression
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Schizophrenic patients without apparent deficit in affective expression
Number of subjects: 58

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 58
Study: 2161301

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 34413

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 29305407

Group type: EXPERIMENTAL
Intervention: Volume targeting at 4 mL/kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Volume targeting at 5 mL/kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Volume targeting at 6 mL/kg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Volume targeting at 7 mL/kg
Number of subjects: 18
Study: 28973227

Group type: EXPERIMENTAL
Intervention: Early resuscitation protocol for sepsis (n=107) including intravenous fluid bolus administration, vasopressors targeting mean arterial pressure (≥65 mm Hg), and blood transfusion for hemoglobin <7 g/dL.
Number of subjects: 209

Group type: COMPARATOR
Intervention: Usual care (n=105) determined by treating clinicians.
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Early resuscitation protocol for sepsis (n=107)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Usual care (n=105)
Number of subjects: 209
Study: 26294062

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1 mA for 15 min)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Dual‐hemisphere tDCS (1 mA for 15 min)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham tDCS (1 mA for 15 min)
Number of subjects: 18
Study: 23740688

Group type: EXPERIMENTAL
Intervention: Hot-wire device
Number of subjects: 22

Group type: COMPARATOR
Intervention: Shaving (Control)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Comparison of hot-wire device and shaving
Number of subjects: 22
Study: 20829069

Group type: EXPERIMENTAL
Intervention: Levosimendan at 0.05 μg/kg/min
Number of subjects: 41

Group type: COMPARATOR
Intervention: Milrinone at 0.4 μg/kg/min
Number of subjects: 41
Study: 19391532

Group type: EXPERIMENTAL
Intervention: Electroacupuncture at Neiguan (PC 6) and Quze (PC 3) combined with routine western medicine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Routine western medicine
Number of subjects: 32
Study: 18035079

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparins (LMWHs)
Number of subjects: 27758

Group type: COMPARATOR
Intervention: Unfractionated heparin (UFH)
Number of subjects: 27758
Study: 15487806

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 0.8 g, 3 times daily for 6 days
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (ASC) 0.48 g, 3 times daily for 6 days
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination of ASA and ASC
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no ASA or ASC)
Number of subjects: 45
Study: 11230785

Group type: EXPERIMENTAL
Intervention: Hormone-replacement therapy (HRT) with conjugated equine estrogen and medroxyprogesterone acetate for 6 months
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: HRT
Number of subjects: 47
Study: 9669827

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate 250 microg twice daily via the Diskus/Accuhaler inhaler (D/A)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Fluticasone propionate 250 microg twice daily via the Diskhaler (DH)
Number of subjects: 364
Study: 8000726

Group type: EXPERIMENTAL
Intervention: Combination of metoclopramide and dexamethasone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ondansetron
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexamethasone alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination antiemetic regimens (5‐HT3 antagonist, dexamethasone, benzodiazepine)
Number of subjects: 0
Study: 2834929

Group type: EXPERIMENTAL
Intervention: Flunitrazepam (Rohypnol) 0.03 mg/kg body weight
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pethidine alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pethidine plus flunitrazepam
Number of subjects: 0
Study: 31686093

Group type: EXPERIMENTAL
Intervention: NPT088 treatment for 6 months
Number of subjects: 0
Study: 28110513

Group type: EXPERIMENTAL
Intervention: Methylnaltrexone (MNTX)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Naloxone (NA)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 15
Study: 25278093

Group type: EXPERIMENTAL
Intervention: Low-sodium diet
Number of subjects: 47

Group type: COMPARATOR
Intervention: Regular-sodium diet
Number of subjects: 47
Study: 23445141

Group type: EXPERIMENTAL
Intervention: Metformin 500 mg b.d.
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg o.d.
Number of subjects: 35
Study: 21569613

Group type: EXPERIMENTAL
Intervention: Mental illness vignette (N = 356)
Number of subjects: 654

Group type: COMPARATOR
Intervention: Diabetes vignette (N = 298)
Number of subjects: 654
Study: 19527321

Group type: EXPERIMENTAL
Intervention: Nebivolol (doses >= 2.5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nebivolol (doses >= 5 mg in non-obese and >= 2.5 mg in obese patients)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16432390

Group type: EXPERIMENTAL
Intervention: Task-oriented exercise program with altered sensory input
Number of subjects: 16

Group type: COMPARATOR
Intervention: Task-oriented exercise program without altered sensory input (control group)
Number of subjects: 16
Study: 15097035

Group type: EXPERIMENTAL
Intervention: Once-daily omeprazole (1 x 20 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Twice-daily omeprazole (2 x 20 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Baseline (no treatment)
Number of subjects: 15
Study: 11147927

Group type: EXPERIMENTAL
Intervention: Sertraline (initial dose 50 mg, titration up to 100 mg)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Amitriptyline (75 mg, up to 150 mg)
Number of subjects: 240
Study: 9496203

Group type: EXPERIMENTAL
Intervention: Whole body cooling (approximately 31 degrees C) during cardiopulmonary bypass
Number of subjects: 26

Group type: COMPARATOR
Intervention: Warm stimulation (approximately 36 degrees C) during cardiopulmonary bypass
Number of subjects: 26
Study: 8468314

Group type: EXPERIMENTAL
Intervention: Adinazolam sustained release, N = 89, treatment duration 4 weeks
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo, N = 91, treatment duration 4 weeks
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Recurrent MD history
Number of subjects: 180
Study: 3101636

Group type: EXPERIMENTAL
Intervention: Trimetazidine (20 mg per tablet, 3 tablets a day for one month)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 31970593

Group type: EXPERIMENTAL
Intervention: Dotinurad (0.5 mg/day, titrated to 2 mg/day)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Febuxostat (10 mg/day, titrated to 40 mg/day)
Number of subjects: 203
Study: 30143441

Group type: EXPERIMENTAL
Intervention: Indocyanine green dye with near-infrared fluorescence imaging
Number of subjects: 180

Group type: COMPARATOR
Intervention: Isosulfan blue dye
Number of subjects: 180
Study: 26432571

Group type: EXPERIMENTAL
Intervention: Continue statin medications
Number of subjects: 244

Group type: COMPARATOR
Intervention: Discontinue statin medications
Number of subjects: 244
Study: 24872333

Group type: EXPERIMENTAL
Intervention: Ceftiofur crystalline‐free acid (CCFA) administered to all steers in a pen
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Ceftiofur crystalline‐free acid (CCFA) administered to one steer in a pen
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Chlortetracycline administration after CCFA treatment
Number of subjects: 176
Study: 22354772

Group type: COMPARATOR
Intervention: Conventional pulmonary vein isolation (CPVI)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Multi-electrode ablation (MEA)
Number of subjects: 185
Study: 20015599

Group type: EXPERIMENTAL
Intervention: OROS methylphenidate (MPH) 72mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Both groups (MPH and PL)
Number of subjects: 24
Study: 18352852

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0
Study: 15962644

Group type: EXPERIMENTAL
Intervention: Oral clonidine 300 microg (n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (n = 25)
Number of subjects: 50
Study: 12699020

Group type: EXPERIMENTAL
Intervention: Standard parent-child interaction therapy (PCIT; STD)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Modified PCIT (abbreviated treatment)
Number of subjects: 54

Group type: COMPARATOR
Intervention: No-treatment waitlist control group (WL)
Number of subjects: 54
Study: 11397498

Group type: EXPERIMENTAL
Intervention: Active participation of mothers during speech therapy sessions
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group with no active participation of mothers
Number of subjects: 59
Study: 9506597

Group type: EXPERIMENTAL
Intervention: Stroke unit
Number of subjects: 550

Group type: COMPARATOR
Intervention: General medical ward
Number of subjects: 550